-Elizabeta Nemeth Researcher Activity Profile

Research Author Detailed Information 

Elizabeta Nemeth Publication Rate By Year

Elizabeta Nemeth has published 3 paper(s) in 2006, 10 paper(s) in 2007, for a total of 13 research publications in total.

Elizabeta E Nemeth Author Information

LAST NAME: nemeth

FIRST NAME: Elizabeta

INITIALS: e

AFFILIATION:

Papers

Elizabeta Nemeth's Publication Record

1. DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis. Year Published: 2006
2. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Year Published: 2006
Center for Inflammatory Bowel Disease and Divisions of Gastroenterology and Nutrition, Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.
3. Urinary hepcidin in congenital chronic anemias. Year Published: 2006
Division of Hematology/Oncology, Children's Hospital, Boston, Massachusetts, USA.
4. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Year Published: 2007
Department of Pathology, School of Medicine, University of Utah, Salt Lake City, UT 84132, USA.
5. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Year Published: 2007
Departments of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1690, USA.
6. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Year Published: 2007
7. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Year Published: 2007
Department of Clinical Medicine and Centre for Diagnosis and Therapy of Hemochromatosis, University of Milano-Bicocca, San Gerardo Hospital, Monza, Milan, Italy.
8. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Year Published: 2007
Department of Clinical Medicine and Prevention, Milano-Bicocca University, San Gerardo Hospital, Monza, Italy.
9. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Year Published: 2007
Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), 10833 Le Conte Ave., Los Angeles, CA 90095, USA.
10. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Year Published: 2007
Department of Clinical Medicine and Centre for Diagnosis and Therapy of Hemochromatosis, University of Milano-Bicocca, San Gerardo Hospital, Monza, Milan, Italy.
11. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Year Published: 2007
Department of Clinical Medicine and Prevention, Milano-Bicocca University, San Gerardo Hospital, Monza, Italy.
12. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Year Published: 2007
Departments of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1690, USA.
13. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Year Published: 2007
Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.